Intravenous ondansetron for the control of opioid-induced nausea and vomiting

Clinical Therapeutics

Volumn 21, Issue 7, 1999, Pages 1216-1227

  Sussman, Glen ^a   Shurman, Joseph ^b   Creed, Mary R ^c   Larsen, L Scott ^d   Ferrer Brechner, Therese ^e   Noll, Donald ^f   Allegra, John ^g   Montgomery, Richard ^h   Schreck, David ⁱ   Grafstein, Eric ^j   Ramalanjaona, Georges ^k   Patel, Vinod ^l   Ducharme, James ^m   Ortenwall, Per ⁿ   Foster, Elizabeth ^o   Ames, Michael ^c  

^a Illinois Center for Clinical Trials   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

^c GLAXOSMITHKLINE   (United States)

^d Bayshore Community Hospital   (United States)

^e Advanced Pain Medicine   (United States)

^f UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^g MORRISTOWN MEMORIAL HOSPITAL   (United States)

^h FORSYTH MEDICAL CENTER   (United States)

ⁱ Muhlenberg Regional Medical Center   (United States)

^j ST PAUL S HOSPITAL   (Canada)

^k NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^l Health Sciences Centre St John's   (Canada)

^m SAINT JOHN REGIONAL HOSPITAL   (Canada)

ⁿ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^o GLAXOSMITHKLINE   (United Kingdom)

more..

Author keywords

Nausea; Ondansetron; Opioids; Pain; Vomiting

Indexed keywords

COCODAMOL; FENTANYL; HYDROCODONE; HYDROMORPHONE; MORPHINE; ONDANSETRON; OPIATE; PETHIDINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ANALGESIA; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 0032807846     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80024-7     Document Type: Article

References (13)

1. 1. McPhee SJ, Schroeder AS. General approach to patient, health maintenance and disease prevention, and common symptoms. In: Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis and Treatment. 35th ed. Stamford, Conn: Appleton & Lange; 1996:11-21.
2. 2. Turturro MA, Paris PM. Oral narcotic analgesics. Postgrad Med. 1991;90:89-95.
3. 3. Schug AS, Zech D, Grond S. Adverse effects of systemic opioid analgesics. Drug Saf. 1992;7:200-213.
4. 4. Jaffe JH, Martin WM. Opioid analgesics and antagonists. In: Goodman L, Gilman A, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990:485-521.
5. 5. Tobias JD. Management of minor adverse effects encountered during narcotic administration. J Post Anesth Nurs. 1993; 8:96-100.
6. 6. Portenoy RK. Management of common opioid side effects during long-term therapy of cancer pain. Ann Acad Med. 1986; 3:4-15.
7. 7. Physicians' Desk Reference®. 52nd ed. Montvale, NJ: Medical Economics Company, Inc; 1998.
8. 8. Butcher ME. Global experience with ondansetron and future potential. Oncology, 1993;50:191-197.
9. 9. McKenzie R, Kovac A, O'Connor T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology. 1993;78:21-28.
10. 3 antagonist ondansetron, Anesthesiology. 1993;78:15-20.
11. 11. Hesketh PJ, Gandara DR. Scrotonin antagonists: A new class of antiemetic agents. J Natl Cancer Inst. 1991;83:613-620.
12. 12. Koch GG, Carr GJ, Amara IA, et al. Categorical data analysis. In: Berry DA, ed. Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel Dekker Inc; 1990:391-475.
13. 13. Rung GW, Claybon L, Hord A, et al. Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. Anesth Analg. 1997;84:832-838.